FindTrial
Sign In

Ocular hypotensive effects of prostaglandin analogues in Japanese patients with normal tension glaucoma: a literature review

Ocular hypotensive effects of prostaglandin analogues in Japanese patients with normal tension glaucoma: a literature review - Literature review of ocular hypotensive efficacy of PGA

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000032344
Enrollment
Unknown
Registered
2018-06-01
Start date
2018-02-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Sponsors

Santen Pharmaceutical Co., Ltd.
Lead Sponsor
Takeo Fukuchi (Professor, Department of Ophthalmology, University of Niigata)
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)unoprostone or latanoprost or travoprost or bimatoprost or tafluprost 2)glaucoma 3)Japan or Japanese

Exclusion criteria

Exclusion criteria: 1)Non-clinical study 2)Not include NTG patient 3)Not include Japanese patient 4)Not original article (review, conference abstract, small case study) 5)No IOP measuring 6)Not PGA monotherapy 7)Not naive or No washout period

Design outcomes

Primary

MeasureTime frame
1)The weighted ocular hypotensive efficacy 2)Regression equation of ocular hypotensive efficacy for each medication.—

Countries

Japan

Contacts

Public ContactYasutaka Takagi

Santen Pharmaceutical Co., Ltd. Japan Medical Affairs Group

clinical@santen.com+81-6-4802-9337

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026